Mathew Cherian, MBBS

Dr. Cherian specializes in the clinical care of patients with breast cancer and in using molecular techniques to dissect the pathogenesis of cancer. His current research interests include: the pathogenesis of endocrine resistance in metastatic breast cancer and the design of therapies to target patients who have progressed while on 1st line therapy; the role of matri-cellular proteins in invasive behavior of inflammatory breast cancer; strategies to reduce chemotherapy resistance in early stage triple negative breast cancer to improve response rates to neo-adjuvant chemotherapy; and the role of interferon induced genes in breast cancer pathogenesis